Notable’s predictive precision medicine platform Identifies Responders with 92% Accuracy*
Notable’s platform accuracy has been demonstrated across multiple hematological malignancies and is expanding to more indications. The utility of the platform ranges across therapeutic modalities from small molecules, biologics, to cell therapies.
*Blood Advances, Spinner (Stanford University), et al. 2020